Your browser doesn't support javascript.
loading
Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia.
Chartomatsidou, Elisavet; Ntoufa, Stavroula; Kotta, Konstantia; Rovida, Alessandra; Akritidou, Maria Anna; Belloni, Daniela; Ferrero, Elisabetta; Trangas, Theoni; Stavroyianni, Niki; Anagnostopoulos, Achilles; Rosenquist, Richard; Ghia, Paolo; Papakonstantinou, Nikos; Stamatopoulos, Kostas.
Afiliação
  • Chartomatsidou E; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Ntoufa S; Department of Biological Applications and Technology, University of Ioannina, Ioannina, Greece.
  • Kotta K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Rovida A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Akritidou MA; Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
  • Belloni D; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Ferrero E; Department of Biological Applications and Technology, University of Ioannina, Ioannina, Greece.
  • Trangas T; Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
  • Stavroyianni N; Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
  • Anagnostopoulos A; Department of Biological Applications and Technology, University of Ioannina, Ioannina, Greece.
  • Rosenquist R; Department of Hematology-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Ghia P; Department of Hematology-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Papakonstantinou N; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; and.
  • Stamatopoulos K; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Blood Adv ; 3(12): 1891-1896, 2019 06 25.
Article em En | MEDLINE | ID: mdl-31227476
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Transdução de Sinais / Proteína Potenciadora do Homólogo 2 de Zeste Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Transdução de Sinais / Proteína Potenciadora do Homólogo 2 de Zeste Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article